[Hepato-biliary effect of the rifomycin-isoniazid combination. II. Histological study on tuberculized mice].
D000818:Animals; D000995:Antitubercular Agents / Q000633:toxicity*; D004357:Drug Synergism; D005260:Female; D007538:Isoniazid / Q000633:toxicity*; D008099:Liver / Q000187:drug effects*; D008168:Lung / Q000473:pathology; D008297:Male; D051379:Mice; D010179:Pancreas / Q000473:pathology; D012293:Rifampin / Q000633:toxicity*
D000995:Antitubercular Agents; D007538:Isoniazid; D012293:Rifampin
Effets hépato-biliaires de l'association rifampicine-isoniazide. II. Etude histologique chez la souris tuberculisée.